Prednisone Market Trends

  • Report ID: 5384
  • Published Date: Jan 03, 2025
  • Report Format: PDF, PPT

Prednisone Sector: Growth Drivers and Challenges

Growth Drivers

  • Surge in COVID-19 Cases - Around the world coronavirus (COVID-19) cases reported close to 767 million as of June 13, 2023. Furthermore, a significant number of patients display severe COVID-19 symptoms, which usually involve low blood oxygen, pneumonia-like symptoms, and severe respiratory distress. Excessive immune system stimulation is experienced by those with severe or serious COVID-19, and this may have detrimental effects on their health. Prednisolone helps to reduce this overstimulation by regulating the immune system's responses to make sure they are both beneficial and do not damage the person. According to the WHO, the readily accessible data, containing information from 7000 individuals with low oxygen levels across 8 clinical trials, demonstrate that corticosteroids lower the number of fatalities from COVID-19. According to the results of these studies, treating patients with severe COVID-19 with corticosteroids during their illness decreases mortality by 20%. Eliminating the requirement for ventilation—which involves placing patients on a machine to assist with breathing—has other advantages.

  • Rise in Prevalence of Irritable Bowel - Scholars have examined the purpose of inflammation in the condition known as irritable bowel syndrome (IBS). According to studies, IBS symptoms might be triggered by inflammation brought on by an infection, and some people with the condition might suffer from persistent inflammation. As a consequence, prednisone use is growing since it has anti-inflammatory properties.
  • Growth in Geriatric Population - Older people are more prone to increased risk of age-related liver, renal, or cardiac issues which could further cause fatality among them. The physiological changes brought on by ageing, weakened immune systems, and multimorbidity render older adults greater vulnerable to infections and increase their risk of experiencing severe illness along with serious complications. These factors are just a few of the reasons why different diseases have a greater impact on older people. Additionally, elderly people are far more probable to develop a serious illness after contracting COVID-19. Hence, the importance of prednisone is growing among geriatric population.

Challenges

  • Side Effects Related to Prednisone – When prednisone is taken in high quantity its further cause various side effects. Common side effects include weight gain, mild mood change, insomnia, and more. However, there could be more severe side effects. An extremely irritable stomach or feeling ill (vomiting), severe vertigo or fainting, muscle weakness, extreme exhaustion, mood swings, appetite loss, and weight loss all serve as indicators of adrenal gland side effects. Furthermore, when children and teenagers take higher amounts of prednisolone over an extended period of time, their normal growth may be slowed down.

  • Lack of Awareness Among People Regarding Prednisone – A Large number of people are unaware of the benefits of this medication. Furthermore, in low income countries since the healthcare sector lacks development, this medication is not known to all and unaware about the quantity it should be used. Hence, a large number of time many people fall prey to its side effects. Therefore, this factor could impede the growth in the revenue of the market.
  • High Price of Prednisone

Base Year

2024

Forecast Year

2025-2037

CAGR

5.3%

Base Year Market Size (2024)

USD 6.32 billion

Forecast Year Market Size (2037)

USD 12.37 billion

Regional Scope

  • North America (U.S., and Canada)
  • Asia Pacific (Japan, China, India, Indonesia, Malaysia, Australia, South Korea, Rest of Asia Pacific)
  • Europe (UK, Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Latin America (Mexico, Argentina, Brazil, Rest of Latin America)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of prednisone is assessed at USD 6.6 billion.

The prednisone market size was over USD 6.32 billion in 2024 and is projected to reach USD 12.37 billion by 2037, growing at around 5.3% CAGR during the forecast period i.e., between 2025-2037. The market growth is impelled by surge in covid-19 cases, rise in prevalence of irritable bowel, and growth in geriatric population.

North America industry is estimated to hold largest revenue share of 35% by 2037, due to rising prevalence of asthma in the region.

The major players in the market are Pfizer Inc., Merck & Co., Inc., GSK plc, Sanofi, and others.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos